Evaluation of objective response, disease control and progression-free survival as surrogate end-points for overall survival in anti–programmed death-1 and anti–programmed death ligand 1 trials
| Autor: | Nie, Run-Cong, Chen, Fo-Ping, Yuan, Shu-Qiang, Luo, Ying-Shan, Chen, Shi, Chen, Yong-Ming, Chen, Xiao-Jiang, Chen, Ying-Bo, Li, Yuan-Fang, Zhou, Zhi-Wei |
|---|---|
| Zdroj: | In European Journal of Cancer January 2019 106:1-11 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect